Trihexyphenidyl hydrochloride
Brand names: Broflex
Trihexyphenidyl hydrochloride is an antimuscarinic (anticholinergic) agent used in Parkinson's disease, particularly for tremor, and for drug-induced extrapyramidal symptoms.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It blocks central muscarinic acetylcholine receptors, helping to restore the dopamine-acetylcholine balance in the basal ganglia.
Prescribing in practice
- Antimuscarinic adverse effects and confusion are common, so it should be avoided or used very cautiously in older or cognitively impaired patients in whom it can precipitate delirium.
- It is contraindicated or hazardous in narrow-angle glaucoma, significant urinary retention, prostatic enlargement and gastrointestinal obstruction.
- It should not be withdrawn abruptly, and additive effects occur with other anticholinergic drugs.
Monitoring
Monitor cognition, mood, intraocular and urinary symptoms, and motor response during treatment.
Counselling the patient
- Report dry mouth, blurred vision, difficulty passing urine, constipation or confusion.
- Avoid stopping the medicine suddenly.
- Be cautious with other medicines that cause dry mouth or drowsiness.
Evidence & guidelines
Antimuscarinics such as trihexyphenidyl have a long-established but limited role in Parkinson's disease, mainly for tremor, as reflected in standard guidance.
Reference: NICE NG71; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS